Nature of business:
Seven years after the foundation of Helsinn, in 1983, Helsinn Chemicals S.A., now Helsinn Advanced Synthesis S.A., was inaugurated as the Group.s first production plant. Since then Helsinn has opened other chemical and pharmaceutical manufacturing facilities in Switzerland and Ireland.
The plants are approved by the Swiss and Irish authorities and by the US FDA, EMA, PIC and Japanese PMDA as well as by several other national boards.
From early 2000 all Swiss plants were ISO 14001 certified, confirming Helsinn.s commitment towards protection of the environment according to International and Swiss laws. The continuous work on HSE has also led to the OHSAS 18001 certification of the Swiss site in 2005, as the first chemical plant ever in Switzerland.
Recently, large investments have increased its production capacity but, more importantly, have added new technologies thus increasing the production flexibility.
Parent company:
• Helsinn Holding S.A., P.O. Box 357, 6915 Lugano/Pambio-Noranco (CH), Tel: +41 (0) 91 985.21.21, Fax: +41 (0) 91993.21.22, info-HHC@helsinn.com
Sister company:
• Helsinn Healthcare S.A., P.O. Box 357, 6915 Lugano/Pambio-Noranco (CH), Tel: +41 (0) 91 985.21.21, Fax: +41 (0) 91 993.21.22, info-HHC@helsinn.com
• Helsinn Birex Pharmaceuticals Ltd., Damastown, Mulhuddart . Dublin 15 (IE), Tel: +353 (0) 1 822.54.04, Fax: +353 (0) 1 822.54.10, info-HBP@helsinn.com
• Helsinn Therapeutics (U.S.), Inc., 1140 US Highway 22, Suite 101,, Bridgewater, New Jersey 08807 (US), Tel: +1 908 231 1435, Fax: +1 908 231 1459, info-HTU@helsinn.com
Statutory auditors:
• Ernst & Young AG, Lugano
0918730111
